Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05940688
Other study ID # 300009897
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 17, 2023
Est. completion date January 31, 2025

Study information

Verified date July 2023
Source University of Alabama at Birmingham
Contact Rosylen "Roz" Quinney
Phone 205.934.1309
Email p3oppy@uabmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-effective strategies to enhance access to quality health information, care, and experiences during pregnancy, postnatal and postpartum/preconception periods, particularly for Black and under-served populations. Collectively, the investigators will collaborate with pregnant and postpartum individuals and their families, hospitals, and communities to discover ways to reduce racism and social problems that contribute to poor health outcomes.


Description:

Feasibility Study Aims 1. To assess the feasibility of the digital health (DHI) and community health worker (CHW) interventions by assessing participant acceptance and use of the intervention. 2. To assess study enrollment to determine appropriateness and usefulness of the inclusion and exclusion criteria to estimate enrollment duration in the planned trial. 3. To determine the number of prenatal visits and the incidence of some of the maternal and neonatal outcomes (ones with higher prevalence) or surrogate outcomes that will be targeted in the planned factorial design randomized controlled trial. (Data will be collected on all relevant maternal and neonatal outcomes. The randomized feasibility design will allow for effect size estimates of the intervention on the incidence of maternal and neonatal outcomes, which will aid in determining the appropriate target outcomes as well as power calculation of the more definitive trial.) The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/infant health care. The promise of digital health and community health worker engagement makes PᵌOPPY interventions potentially transformative, sustainable, and scalable for Non-Hispanic Black mothers and their infants from under-served communities in Alabama and beyond. The objective of this pilot study is to determine if it is feasible to randomize and implement digital health and community health worker interventions. Design Summary The investigators will challenge existing care paradigms by testing the effectiveness of integrating innovative platforms into the existing healthcare system, including existing digital health and community health worker programs from within the EQUATE consortium, to eliminate critical barriers to equitable healthcare access. After seeking input from a Community Advisory Board, these interventions will be refined and deployed for pilot testing. Individuals in Non-Hispanic Black communities at the highest risk of adverse pregnancy outcomes which were historically underrepresented in clinical research due to structural racism will be included. The investigative team employs experts across the community, maternal, and infant health continuum. For this pilot, 40 eligible participants will be randomized, 10 to usual care, 10 to DHI, 10 to CHW, and 10 to DHI + CHW


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date January 31, 2025
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender Female
Age group 16 Years to 49 Years
Eligibility Inclusion Criteria: - Self Identifies as Non-Hispanic Black - Between 16-49 years old - Pregnant individuals between 8° - 226 weeks gestational age - Live singleton or dichorionic twin gestation - Dating sonogram at <23 weeks gestation - Area Deprivation Index (ADI) National 4th or 5th Quintile - Planning to deliver at UAB Hospital - Speaks and writes in English - No indication for delivery at the time of enrollment Exclusion Criteria: - Declines randomization - Speaks or writes in languages other than English - Currently incarcerated - Fetal demise diagnosed prior to enrollment - Known major structural chromosomal abnormalities prior to enrollment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Digital Health intervention
Health care information delivered via a link in a text message that is then opened in a secure browser.
Community Health Worker
Health care information delivered via CHW.
Digital Health Intervention plus Community Health Worker
Health care information delivered via DHI plus CHW

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (4)

Lead Sponsor Collaborator
University of Alabama at Birmingham American Heart Association, ConnectionHealth, Memora Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Participant acceptance of randomization arm / intervention Participant acceptance is defined as a yes response to this question:
"I would recommend the care I received to someone in a similar situation."
From randomization to 6 weeks postpartum
Primary Participant use of digital health and/or community health worker interventions Use of the intervention for the digital health arm(s) is defined as the % of opened text messages. Use of the intervention for the community health worker arm(s) is defined as the % of planned sessions in which the participant engages with the community health worker. From randomization to 6 weeks postpartum
Secondary Outpatient Prenatal Care Visits Number of outpatient prenatal care and postpartum visits Duration of pregnancy through 6 weeks postpartum
Secondary Preterm Birth Delivery of a neonate at less than 37 weeks At birth
Secondary Neonatal birthweight Weight of neonate at birth At birth
Secondary Cesarean delivery Occurrence of a cesarean birth At birth
Secondary Maternal blood transfusion Transfusion of blood products Duration of pregnancy through 6 weeks postpartum
Secondary Breastfeeding intent Participant's self-reported intent of whether or not to express breast milk upon admission to the delivery-associated hospitalization From randomization to delivery of the infant(s)
Secondary Vaccination rate The number of recommended vaccinations for which the mother and newborn accepted Pregnancy through 6 weeks postpartum / 6 weeks of life
Secondary Maternal postpartum readmission Admission of the mother to the hospital after discharge from the delivery-associated hospitalization From discharge from the delivery-associated hospitalization to 6 weeks postpartum
Secondary Neonatal hospital readmission Admission of a neonate to the hospital after discharge from the hospital after birth Birth to 6 weeks of life
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02520687 - Effects of Dietary Nitrate in Hypertensive Pregnant Women Phase 1